We are live on
!
Find out more
RI
Ridgewood Investments Portfolio holdings
AUM
$267M
This Fund
S&P 500
This Quarter
Est. Return
+4.2%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$163M
AUM Growth
+$22.7M
(+16%)
Cap. Flow
+$22.4M
Cap. Flow
% of AUM
13.74%
Top 10 Holdings %
Top 10 Hldgs %
23.65%
Holding
833
New
632
Increased
56
Reduced
89
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$3.48M |
| 2 |
ALPS Medical Breakthroughs ETF
SBIO
|
+$851K |
| 3 |
RB Global
RBA
|
+$600K |
| 4 |
Baxter International
BAX
|
+$535K |
| 5 |
International Flavors & Fragrances
IFF
|
+$451K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$955K |
| 2 |
Cardinal Health
CAH
|
+$806K |
| 3 |
Deere & Co
DE
|
+$621K |
| 4 |
Kimberly-Clark
KMB
|
+$594K |
| 5 |
Goldman Sachs
GS
|
+$544K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.03% |
| 2 | Healthcare | 10.58% |
| 3 | Technology | 8.88% |
| 4 | Industrials | 7.49% |
| 5 | Consumer Discretionary | 6.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
T. Rowe Price
TROW
$24.3B
| $788K | 0.48% |
6,983
-127
| -2% | -$14.5K |
|
52
eBay
EBAY
$49.8B
| $788K | 0.48% |
17,749
-201
| -1% | -$9.21K |
|
53
Amgen
AMGN
$222B
| $782K | 0.48% |
3,235
+1,719
| +113% | +$422K |
|
54
Newmont
NEM
$119B
| $774K | 0.47% |
15,792
+2,189
| +16% | +$106K |
|
55
Middleby
MIDD
$6.08B
| $770K | 0.47% |
5,254
-7
| -0.1% | -$1.04K |
|
56
Axos Financial
AX
$5.68B
| $737K | 0.45% |
19,963
| – | – |
|
57
United Therapeutics
UTHR
$23.1B
| $717K | 0.44% |
3,200
| – | – |
|
58
Invesco S&P International Developed Low Volatility ETF
IDLV
$348M
| $715K | 0.44% |
26,117
-1,621
| -6% | -$44.2K |
|
59
HubSpot
HUBS
$10.5B
| $713K | 0.44% |
1,662
| – | – |
|
60
PayPal
PYPL
$50.5B
| $712K | 0.44% |
9,381
-189
| -2% | -$14.6K |
|
61
Philips
PHG
$26.1B
| $707K | 0.43% |
45,025
-1,461
| -3% | -$21K |
|
|
62
Goldman Sachs
GS
$303B
| $703K | 0.43% |
2,149
-1,563
| -42% | -$544K |
|
63
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.8B
| $702K | 0.43% |
6,407
+582
| +10% | +$63K |
|
64
Oracle
ORCL
$423B
| $686K | 0.42% |
7,387
-232
| -3% | -$20.3K |
|
65
Huntington Bancshares
HBAN
$35.5B
| $676K | 0.41% |
60,348
-2,501
| -4% | -$34.8K |
|
66
Core Laboratories
CLB
$521M
| $669K | 0.41% |
30,331
-168
| -0.6% | -$3.93K |
|
67
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.9B
| $664K | 0.41% |
13,840
+253
| +2% | +$11.4K |
|
68
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$2.97B
| $661K | 0.4% |
21,720
+2,141
| +11% | +$65.3K |
|
69
Boeing
BA
$185B
| $659K | 0.4% |
3,101
-501
| -14% | -$104K |
|
70
Walt Disney
DIS
$181B
| $653K | 0.4% |
6,522
+1,544
| +31% | +$156K |
|
71
Bristol-Myers Squibb
BMY
$132B
| $653K | 0.4% |
9,417
| – | – |
|
72
Takeda Pharmaceutical
TAK
$55.7B
| $650K | 0.4% |
39,461
| – | – |
|
73
Aon
AON
$76B
| $644K | 0.39% |
2,041
| – | – |
|
74
iShares 0-5 Year TIPS Bond ETF
STIP
$15.9B
| $638K | 0.39% |
6,432
+938
| +17% | +$91.7K |
|
75
Conagra Brands
CAG
$7.23B
| $629K | 0.39% |
16,756
-500
| -3% | -$18.5K |
|
Similar funds
IP
CFG
EU
PC
TGI
TWM
SP
EAIC
Ridgewood Investments's Q1 2023 Portfolio in Review
As of Q1 2023, Ridgewood Investments held 833 positions worth $163M, up 16% from $141M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ridgewood Investments deployed $22.4M of net new capital in Q1 2023, opening 632 new positions and adding to 56 existing holdings. Its largest new stake was ALPS Medical Breakthroughs ETF: 28,200 shares worth $21.9K.
By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 26% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $955K trimmed.
- Ridgewood Investments's largest Q1 2023 buy was ALPS Medical Breakthroughs ETF: 28,200 shares worth $21.9K.
- Ridgewood Investments added most to Vanguard Short-Term Treasury ETF in Q1 2023, an estimated $3.48M increase.
- Ridgewood Investments's biggest Q1 2023 reduction was Gilead Sciences, cutting an estimated $955K.
- Ridgewood Investments fully exited SRAX, Inc. Class A Common Stock in Q1 2023, selling an estimated $278K.
- Ridgewood Investments's ten largest holdings make up 24% of its $163M portfolio in Q1 2023.
- Ridgewood Investments opened 632 new positions and closed 4 in Q1 2023.
- Ridgewood Investments's portfolio value rose 16% quarter-over-quarter to $163M.
Based on Ridgewood Investments's 13F filing for Q1 2023, filed 25 Apr 2023.